Using Biologics in Inflammatory Arthritis: Assessing the Risks and Benefits

Canadian Journal of General Internal Medicine
doi 10.22374/cjgim.v8i0.106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Dougmar Publishing Group, Inc.

Related search

Value of Information Analysis for Assessing Risks and Benefits of Nanotechnology Innovation

Environmental Sciences Europe
Pollution
2019English

Risks and Benefits

Nature Nanotechnology
Electronic EngineeringCondensed Matter PhysicsMaterials ScienceOpticsMolecular Physics,NanoscienceElectricalAtomicBioengineeringNanotechnologyBiomedical Engineering
2006English

SAT0147 Serum Levels of the Anti-TNF Biologics Correlate With Clinical Efficacy in Patients With Inflammatory Arthritis

2017English

Risks and Benefits in Radiology.

BMJ
1987English

Food Challenges, the Risks and Benefits

Clinical and Experimental Allergy
AllergyImmunology
2017English

Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Global Variations in Biologics Access and Rheumatoid Arthritis Treatment Costs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The Cricoid Debate - Balancing Risks and Benefits

Anaesthesia
AnesthesiologyPain Medicine
2016English

Weighing the Risks and Benefits of Intervention

Neurology: Clinical Practice
Neurology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy